H Kazamatsuri, C Chien, J O Cole. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adrenergic Agents/therapeutic useAntiparkinson Agents/therapeutic useBasal Ganglia Diseases/chemically inducedBasal Ganglia Diseases/drug therapyBasal Ganglia Diseases/therapyBrain Chemistry/drug effectsDenturesDopamine/metabolismDopamine AntagonistsHumansHypnotics and Sedatives/therapeutic useIatrogenic DiseaseIndoles/therapeutic useMental Disorders/drug therapyMovement Disorders/chemically inducedMovement Disorders/drug therapyMovement Disorders/epidemiologyMovement Disorders/therapyNeurosurgeryPhenothiazines/therapeutic usePiperazines/therapeutic useRemission, SpontaneousSyndromeTranquilizing Agents/adverse effectsTranquilizing Agents/therapeutic useTryptophan/therapeutic use
Substances: See more » Adrenergic AgentsAntiparkinson AgentsDopamine AntagonistsHypnotics and SedativesIndolesPhenothiazinesPiperazinesTranquilizing AgentsTryptophanDopamine
Year: 1972 PMID: 4116201 DOI: 10.1001/archpsyc.1972.01750280059011
Source DB: PubMed Journal: Arch Gen Psychiatry ISSN: 0003-990X